Adrenodoxin reductase is an NADP dependent flavoenzyme which functions as the reductase of mitochondrial P 450 systems. We sequenced two adrenodoxin reductase cDNAs isolated from a bovine adrenal cortex cDNA library. The deduced amino acid sequence shows no similarity to the sequence of the microsomal P 450 systems or other known protein sequences. Nonetheless, by sequence analysis and comparisons with known sequences of dinucleotide-binding folds of two NADP-binding flavoenzymes, two regions of adrenodoxin reductase sequence were identified as the FAD-and NADP-binding sites. These analyses revealed a consensus sequence for the NADP-binding dinucleotide fold (GXGXXAXXXAXXXXXXG, in one-letter amino acid code) that differs from FAD and NAD-binding dinucleotide-fold sequences. In the data base of protein sequences, the NADP-bindingsite sequence appears solely in NADP-dependent enzymes, the binding sites of which were not known to date. Thus, this sequence may be used for identification of a certain type of NADP-binding site of enzymes that show no significant sequence similarity.
Adrenodoxin reductase is the first enzyme in the mitochondrial P-450 systems which catalyze several critical steps in the biosynthesis of steroid hormones in steroidogenic tissues [l -31, and the biosynthesis of bile acids [4, 51 and vitamin D [6] in the liver and kidney, respectively. These P 450 systems are composed of three enzymes which constitute an electron-transfer chain located on the matrix side of the inner mitochondrial membrane [7, 81 . The function of adrenodoxin reductase is to transfer electrons from NADPH to a specific ferredoxin (adrenodoxin), which in turn transfers them one at a time to the P 450 [I, 9, 101. Adrenodoxin reductase cDNA has been recently isolated from both bovine and human steroidogenic tissue cDNA libraries [I 1 -141 and used to demonstrate that adrenodoxin reductase is encoded by a single gene in both genomes [11, 341. Thus, the same adrenodoxin reductase serves the different mitochondrial P 450 systems in steroidogenic tissues.
As an NADP-dependent electron-transfer protein, adrenodoxin reductase belongs to a group of NAD-and NADP-dependent oxidoreductases which constitute a large collection of enzymes that vary widely in their sizes, substrate specificities, and sequences. The structures of a large number of NAD-binding proteins have been studied extensively. Comparisons of the NAD-binding domains of these enzymes indicate that their dinucleotide(ADP)-binding sites share a similar fold which forms a pocket to accomodate the coenzyme [15 -181. The sequences of these binding sites reveal a nearly universally conserved Gly-Xaa-Gly-Xaa-Xaa-Gly sequence which appears at the border between the first /?-sheet strand and the a-helix allowing the formation of a tight turn [17, 181. The structures of only two NADP-binding proteins have been well characterized to date [19, 20] . Glutathione reductase, like adrenodoxin reductase, is an FAD-containing flavoenzyme. The ADP-binding sites in both its FAD and NADP domains form a Lhxp fold similar to that of the NAD-binding site [16, 17, 191 . (For convenience we shall use the terms FAD-and NADP-binding sites to refer to the binding site for the ADP portion of these molecules.) In contrast, the NADP-binding site of dihydrofolate reductase shows a different structure [20] .
In the absence of sequence information on adrenodoxin reductase its structural relationship to other NAD(P)-dependent enzymes remained unknown. In this study we report the cDNA sequence of adrenodoxin reductase and examine its similarity to other oxidoreductases. By sequence comparison and analysis, one region of adrenodoxin reductase is identified as the NADP-binding site, and a modified dinucleotide-binding-site consensus sequence is used to uniquely identify additional NADP-binding enzymes in the protein sequence databases.
MATERIALS AND METHODS
The cDNA of the adrenodoxin reductase plasmid, PAR, was isolated from a lgtl 1 cDNA expression library constructed from bovine adrenal cortex mRNA [Ill. We sequenced an additional cloned cDNA which was identified by rescreening of the cDNA library using the PAR cDNA as a probe.
The DNA sequencing was performed as previously described [21-231. BurnHI, B u d , BsshII, EcoRI, SulI, and XmaI sites and the first AvaI site from the 5' end of clone PAR were used for end-labelling ( Fig. 1) . Secondary digestions were performed with BglI, HphI, KpnI, PstI or one of the enzymes mentioned above.
The NBRF and GenBank sequence databases were searched with the programs Seqnce (Delaney Software, Vancouver, Canada) and MicroGenie [24] on an IBM personal computer, and with the University of Wisconsin-Madison Sequence Analysis Program on a Micro Vax I1 computer. Homology matrix comparisons and hydrophobicity and protein secondary-structure analyses, were performed as described in [23, 251.
RESULTS

The characteristics of the sequenced cDNA
The correct reading frame of the PAR cDNA insert was identified using the sequences of partial tryptic fragments of adrenodoxin reductase which we had determined previously [l 11 (Fig. 1) . Our sequence is in near-perfect agreement with the sequence of Sagara et al. [12] . However, the sequences of these four independent clones show many differences from the cDNA sequence of adrenodoxin reductase recently reported by Nonaka et al. [13] . The differences include many insertions and deletions that alter the reading frame of translation for tens of residues. These discrepancies are probably a result of sequencing errors as their sequence was not cross-checked by sequencing an independent clone.
Adrenodoxin reductase sequence shows no similarity with other oxidoreductase sequences
The comparison of the sequence of adrenodoxin reductase with the NBRF protein sequence database revealed no significant matches with any sequence using the programs noted in Materials and Methods. To detect low but significant similarity between adrenodoxin reductase and other oxidoreductases we carried out homology matrix analyses at low identity cutoff values (> 25%) for segments of 30 residues (the FADand NADP-binding sites are 30 residues in other oxidoreductases). These analyses also failed to reveal similarity between adrenodoxin reductase and other oxidoreductase sequences including microsomal P-450 reductase [26 -281 and spinach ferredoxin reductase [2Y] .
Identijkation of the FAD-binding site of adrenodoxin reductase
In adrenodoxin reductase the dinucleotide-binding site consensus sequence [30] is found only at the amino-terminus region (Fig. 2) . Secondary-structure-prediction analysis of this region provided further support for the identification of this segment as an ADP-binding Pap fold. Sagara et al. [12] also noted that this region may be an FAD-or NADP-binding site. But, as the FAD-binding domains of many flavoenzymes appear to be located close to the amino terminus of the protein, this region is most probably the FAD-binding site of adrenodoxin reductase (Fig. 2) .
Identification of the NADP-binding site of adrenodoxin reductuse NADP-binding site. Hence, we sought a putative NADPbinding site by two criteria: (a) a sequence similarity with the NADP-binding domain of the human glutathione reductase, the crystal structure of which is known [16, 191; and (b) a secondary structure that is similar to a fold. As noted below only one region was found to fulfil both of these criteria.
The sequences of only two NADP-binding enzymes that are similar to the human glutathione reductase are known [37, 421. These three sequences contain a consensus sequence which distinguishes the NADP-binding site from the FADbinding site by the first Ala residue (Fig. 2) . This sequence is also found in adrenodoxin reductase with the substitution of Pro for the last Gly (Pro and Gly are both helix breakers and show a tendency to occur in turns) (Fig.2) .
To check the statistical significance of this match (Fig. 2 ) we searched the NBRF database (release 11) to determine the frequency of the following consensus sequence in the complete population of sequences (in one letter amino acid code, wherein X represents any amino acid): This search yielded only five matches (from nearly 5000 sequences). Two of these were for human glutathione reductase and mercuric reductase (Escherichia coli glutathione reductase was not included in the database; Fig. 2 ). The third matching sequence included only Gly and Ala and was thus eliminated. The fourth match was an NADP-specific glutamate dehydrogenase from Neurospora crassa [34] . The homologous enzyme from E. colicontains one conservative change in the consensus sequence (Fig. 2) . These two sequences show no similarity with other NADP-binding enzymes listed in Fig.2 and there was no previous identification of their NADP-binding sites. The fifth match was a bacteriophage protein [47] . Since the function of this protein is not defined, the significance of the match is not known.
The five matches noted above were a subset of a total of 42 different sequences found when the search was carried by substituting X instead of the last G in consensus sequence 1.
All but one of the remainder (37 sequences), were incompatible with the more detailed consensus sequence shown in Fig.2 . The majority of these were eliminated by a simple rule: if a Pro or a stretch of Gly appears in a position that corresponds to the p-sheet or a-helix portion of sequence 1 it would break the secondary structure [48] and thus would not be compatible with a /lap-fold-forming sequence.
The one exception was the NADP-specific octopinesynthase sequence which showed perfect compatibility with the consensus sequence in Fig. 2 except that the third Gly was moved by one position. This sequence showed no significant similarity with the full sequence of adrenodoxin reductase or any of the other enzymes.
A search for the consensus sequence in recently published NADP-binding enzyme sequences which were not yet included in the NBRF database revealed that NADP-specific 'malic' enzyme also possesses the consensus sequence with the exception of the position of the last Gly (Fig. 2) .
Negative control: NAD-and FAD-binding-site consensus sequences do not recognize any N A DP-binding enzymes
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1050 1080 [31] , fumaratc reductase [32] , glutamate dehydrogenase ( E . coli [33] ; N . crassa [34] ; yeast [35, 36] ), glutathione reductase ( E . coli [37] , human [38] ), lipoamide dehydrogenasc (E. coli [3V]; human [40] ; porcine [I 6, 40] ), 'malic' enzyme [41] , mercuric reductasc (Pseudonzunus) [42] , NADH dehydrogenase [43] , octopine synthase (Agrobucterium) [44] , p-hydroxybenzoate hydroxylase (f.ceudomonrrs) [4S] and putidaredoxin reductase (Pseudomonas putidu) [46] . Abbreviations, DH, dehydrogcnase; H, hydroxylase; R, reductase; Ox, oxidase search of the sequence database using NAD-and FAD-binding consensus sequences should not identify any NADP-binding enzymes. A search of the NBRF library using FAD-and NAD-binding consensus sequence (substituting Gly for the first Ala in consensus sequence 1) indeed identified FAD-and NAD-binding proteins, but it did not identify a single NADPbinding protein. Two of the proteins identified in this search are hypothetical proteins derived from open reading frames [49, 501. Since their sequences inatchcd perfectly the detailed consensus sequence (Fig. 2) , these two hypothetical proteins probably function as oxidoreductases. Yet, whether they bind a dinucleotide remains to be determined.
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Predicted secondary structure of the putative NADP-binding site a profile that is perfectly compatible with a flap-fold structure. Howcver, the profiles for adrenodoxin reductase and 'malic' enzyme showed higher helix potential at the expected position of the second p-sheet strand. The sequence of adrenodoxin reductase shows no other region that fits a pap-fold structure better than this region, despite the difference noted. In an ADP-binding [jag fold the two P-sheet strands form the same p-pleated sheet [19] . It is possible that the second strand was substituted by a different /S-sheet-strand-forming region in the course of evolution.
Analysis of' the hydrophobicity of czdrenodoxin reducrase
Adrenodoxin reductase associates with the inner mitochondria1 membrane within which the P-450 system is located. The hydrophobicity profile using two scales of hydrophobicity [51, 521 did not show any segment that satisThe conformational propensities [48] of the NADP-binding sites of all but two of the enzymes listed in Fig. 2 showed fies the criteria for prediction of a membrane-spanning region in the adrenodoxin reductase sequence. Fig. 2 shared a common ancestor, then the FAD-and NADP-binding sites of these enzymes would be expected to be at similar distances from one another, and this is indeed the case for adrenodoxin reductase (Fig.2) .
At present we do not know the structural significance of the observed sequence differences between NAD-and NADPbinding sites (Fig.2) . Some of the conserved differences may play a role in determining NAD vs. NADP specificity of the binding site. With the availability of the cDNA probes the structural role of the sequences identified in this paper can be examined by the production of altered molecules from cDNA modified using site-directed-mutagenesis techniques.
Wliut Lire the dqfirent types qf NADP-binding sites?
The sequences of several NADP-dependent enzymes do not include the NADP consensus sequence (Fig.2) i.e. cytochrome P-450 reductase [26 -281, spinach ferredoxin reductase [29] , quinone (menadione) reductase [53] , 6-phosphogluconate dehydrogenase [54] and glucose-6-phosphate dehydrogenase [55, 561. Yet, the presence of this consensus sequence in certain NADP-binding enzymes which share no significant overall sequence similarity indicates that its conservation may be mandated by the structural requirements of coenzyme and protein association. Hence, we expect that most if not all NADP-binding sites that are structurally similar to a flu1 fold will have the conserved consensus sequence.
Following the nomenclature of Wierenga et al. [17], we suggest that these be referred to as type I NADP-binding sites. The enzymes that do not have the NADP consensus sequence may represent additional structurally distinct classes.
